Although the role of RBP-4 in the pathogenesis of T2D and CAD is unknown, several studies have hypothesized that RBP-4 elevation causes IR and atherosclerotic CAD via the mitogen-activated protein kinase (MAPK) pathway [15,16,17]. The gene discussed is RBP4; the disease is coronary artery disorder.